Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Ann Surg Oncol. 2014 Feb 20;21(5):1616–1623. doi: 10.1245/s10434-014-3543-7

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

A. Line graph demonstrating baseline and post-treatment levels of serum EGF among pathologic responders and non-responders over time. Mean ± standard error are shown. A repeated measures ANOVA was used to compare repeated measurements over time. B. Line graph demonstrating baseline and post-treatment levels of serum bFGF among pathologic responders and non-responders over time. C. Line graph demonstrating baseline and post-treatment levels of serum VEGF among pathologic responders and non-responders over time. D. Line graph demonstrating baseline and post-treatment levels of serum PDGF-AA among pathologic responders and non-responders over time.